Ischemic heart disease decisions — 2025

The Board denied the veteran's request for an earlier effective date for service connection of hypertension and coronary artery disease. The earliest possible effective dates were already assigned.

Service connection for squamous cell carcinoma, right tonsil is denied. Other issues are remanded for further review.

The Board dismissed appeals related to the effective dates for PTSD and SMC ratings but remanded issues regarding earlier effective dates for TDIU and DEA benefits.

The Board remanded the veteran's claims for service connection for coronary artery disease and prostate cancer due to Agent Orange exposure. The Board needs more evidence, including medical records and examinations.

The Board remanded the veteran's claims for service connection for coronary artery disease, restrictive lung disease, and gastroesophageal reflux disease. The veteran asserted these conditions were caused by exposure to herbicides at Okinawa, Japan, during the Vietnam War Era, as well as other exposures.

The veteran's effective date for service connection of coronary artery disease was granted as December 12, 2022. The evaluation in excess of 10 percent is remanded.

The appeal for an earlier effective date for service connection of coronary artery disease, myocardial infarction, and supraventricular tachycardia was dismissed because a similar appeal was already pending.

The Board denied service connection for the veteran's heart disorder and chronic gastritis, stating that these conditions were not shown to be chronic in service or related to in-service injury or disease.

The veteran's claims for service connection for coronary artery disease and hypertension were granted. The claim for depression was remanded.

The Board denied service connection for leukemia, coronary artery disease, and benign prostatic hyperplasia (BPH). The claim for service connection for a stroke was remanded.

The veteran's claims for higher ratings and earlier effective dates for bilateral hearing loss and tinnitus were denied. The claim for a higher rating for coronary artery disease and TDIU was remanded.

The Board remanded the claims for an earlier effective date for coronary artery disease and service connection for lung cancer due to failures in obtaining relevant medical records and adequate medical opinions.

Service connection for hypertension, MGUS, and CAD is granted. The reduction in the disability rating for a right leg tibia fracture was improper, so the original 20% rating is restored. A compensable disability rating for COPD is denied. Claims for service connection for ED and enlarged prostate are remanded.

The Board remanded all issues to the Agency of Original Jurisdiction for further development, including VA examinations.

The veteran's service connection for coronary artery disease, myocardial infarction, and atrial fibrillation was granted an earlier effective date of September 16, 2021. The issue of an even earlier effective date for special monthly compensation (SMC) at the housebound rate was remanded.

The veteran's claims for higher ratings for service-connected conditions were partially granted. The veteran is entitled to a 60 percent rating for coronary artery disease, a 10 percent rating for diabetic peripheral neuropathy, and a noncompensable rating for erectile dysfunction, all effective May 11, 2021. However, the claim for a compensable rating for prostate cancer was denied.

The veteran's service connection for bladder cancer and hypertension due to herbicide exposure was granted. The claim for a heart condition other than hypertension was denied.

Service connection for bilateral hearing loss, tinnitus, right ankle disability, and coronary artery disease was denied. Service connection for left ankle, right wrist, and left wrist disabilities was remanded.

The Board remanded the veteran's claims for service connection of hepatic steatosis and heart disorder due to exposure at Camp Lejeune. The veteran will receive new examinations.

The veteran's service connection for bladder cancer and hypertension due to herbicide exposure was granted. The claim for a heart condition other than hypertension was denied.